Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
A Brief Synopsis on the Genetics of Alzheimer's Disease.

Current genetic medicine reports

Kamboh MI.
PMID: 30460168
Curr Genet Med Rep. 2018;6(4):133-135. doi: 10.1007/s40142-018-0155-8. Epub 2018 Oct 30.

No abstract available.

Cite
Kamboh MI. A Brief Synopsis on the Genetics of Alzheimer's Disease. Curr Genet Med Rep. 2018;6(4):133-135doi: 10.1007/s40142-018-0155-8.
Kamboh, M. I. (2018). A Brief Synopsis on the Genetics of Alzheimer's Disease. Current genetic medicine reports, 6(4), 133-135. https://doi.org/10.1007/s40142-018-0155-8
Kamboh, M Ilyas. "A Brief Synopsis on the Genetics of Alzheimer's Disease." Current genetic medicine reports vol. 6,4 (2018): 133-135. doi: https://doi.org/10.1007/s40142-018-0155-8
Kamboh MI. A Brief Synopsis on the Genetics of Alzheimer's Disease. Curr Genet Med Rep. 2018;6(4):133-135. doi: 10.1007/s40142-018-0155-8. Epub 2018 Oct 30. PMID: 30460168; PMCID: PMC6223698.
Copy Download .nbib Format: NLM
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.

Molecular psychiatry

DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA.
PMID: 34112972
Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10.

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD, identifies a subgroup with poor outcomes, and is associated...

Cite
DeMichele-Sweet MAA, Klei L, Creese B, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021;26(10):5797-5811doi: 10.1038/s41380-021-01152-8.
DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Alarcón-Martín, E., Valero, S., Liu, Y., Hooli, B., Aarsland, D., Selbaek, G., Bergh, S., Rongve, A., Saltvedt, I., Skjellegrind, H. K., Engdahl, B., Stordal, E., Andreassen, O. A., Djurovic, S., Athanasiu, L., Seripa, D., Borroni, B., Albani, D., Forloni, G., Mecocci, P., Serretti, A., De Ronchi, D., Politis, A., Williams, J., Mayeux, R., Foroud, T., Ruiz, A., Ballard, C., Holmans, P., Lopez, O. L., Kamboh, M. I., Devlin, B., & Sweet, R. A. (2021). Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Molecular psychiatry, 26(10), 5797-5811. https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet, Mary Ann A, et al. "Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease." Molecular psychiatry vol. 26,10 (2021): 5797-5811. doi: https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10. PMID: 34112972; PMCID: PMC8660923.
Copy Download .nbib Format: NLM
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.

Molecular psychiatry

DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA.
PMID: 34112972
Mol Psychiatry. 2021 Jun 10; doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10.

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD, identifies a subgroup with poor outcomes, and is associated...

Cite
DeMichele-Sweet MAA, Klei L, Creese B, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021;doi: 10.1038/s41380-021-01152-8.
DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Alarcón-Martín, E., Valero, S., Liu, Y., Hooli, B., Aarsland, D., Selbaek, G., Bergh, S., Rongve, A., Saltvedt, I., Skjellegrind, H. K., Engdahl, B., Stordal, E., Andreassen, O. A., Djurovic, S., Athanasiu, L., Seripa, D., Borroni, B., Albani, D., Forloni, G., Mecocci, P., Serretti, A., De Ronchi, D., Politis, A., Williams, J., Mayeux, R., Foroud, T., Ruiz, A., Ballard, C., Holmans, P., Lopez, O. L., Kamboh, M. I., Devlin, B., & Sweet, R. A. (2021). Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Molecular psychiatry, . https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet, Mary Ann A, et al. "Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease." Molecular psychiatry vol. (2021). doi: https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021 Jun 10; doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10. PMID: 34112972; PMCID: PMC8660923.
Copy Download .nbib Format: NLM
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.

Molecular psychiatry

DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA.
PMID: 34112972
Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10.

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD, identifies a subgroup with poor outcomes, and is associated...

Cite
DeMichele-Sweet MAA, Klei L, Creese B, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021;26(10):5797-5811doi: 10.1038/s41380-021-01152-8.
DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Alarcón-Martín, E., Valero, S., Liu, Y., Hooli, B., Aarsland, D., Selbaek, G., Bergh, S., Rongve, A., Saltvedt, I., Skjellegrind, H. K., Engdahl, B., Stordal, E., Andreassen, O. A., Djurovic, S., Athanasiu, L., Seripa, D., Borroni, B., Albani, D., Forloni, G., Mecocci, P., Serretti, A., De Ronchi, D., Politis, A., Williams, J., Mayeux, R., Foroud, T., Ruiz, A., Ballard, C., Holmans, P., Lopez, O. L., Kamboh, M. I., Devlin, B., & Sweet, R. A. (2021). Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Molecular psychiatry, 26(10), 5797-5811. https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet, Mary Ann A, et al. "Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease." Molecular psychiatry vol. 26,10 (2021): 5797-5811. doi: https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10. PMID: 34112972; PMCID: PMC8660923.
Copy Download .nbib Format: NLM
Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways.

Current genetic medicine reports

Rosenthal SL, Kamboh MI.
PMID: 24829845
Curr Genet Med Rep. 2014 Mar 22;2:85-101. doi: 10.1007/s40142-014-0034-x. eCollection 2014.

Late-onset Alzheimer's disease (LOAD) is a devastating neurodegenerative disease with no effective treatment or cure. In addition to

Cite
Rosenthal SL, Kamboh MI. Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways. Curr Genet Med Rep. 2014;2:85-101doi: 10.1007/s40142-014-0034-x.
Rosenthal, S. L., & Kamboh, M. I. (2014). Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways. Current genetic medicine reports, 285-101. https://doi.org/10.1007/s40142-014-0034-x
Rosenthal, Samantha L, and Kamboh, M Ilyas. "Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways." Current genetic medicine reports vol. 2 (2014): 85-101. doi: https://doi.org/10.1007/s40142-014-0034-x
Rosenthal SL, Kamboh MI. Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways. Curr Genet Med Rep. 2014 Mar 22;2:85-101. doi: 10.1007/s40142-014-0034-x. eCollection 2014. PMID: 24829845; PMCID: PMC4013444.
Copy Download .nbib Format: NLM
Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)

Hu Z, Wang L, Ma S, Kirisci L, Feng Z, Xue Y, Klunk WE, Kamboh MI, Sweet RA, Becker J, Lv Q, Lopez OL, Xie XQ.
PMID: 30386819
Alzheimers Dement (N Y). 2018 Oct 14;4:542-555. doi: 10.1016/j.trci.2018.09.001. eCollection 2018.

INTRODUCTION: We investigated the effect of antihypertensive (aHTN) medications and cholinesterase inhibitors (ChEIs) on the cognitive decline in patients with Alzheimer's disease (AD) and analyzed synergism by chemogenomics systems pharmacology mapping.METHODS: We compared the effect of aHTN drugs on...

Cite
Hu Z, Wang L, Ma S, et al. Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:542-555doi: 10.1016/j.trci.2018.09.001.
Hu, Z., Wang, L., Ma, S., Kirisci, L., Feng, Z., Xue, Y., Klunk, W. E., Kamboh, M. I., Sweet, R. A., Becker, J., Lv, Q., Lopez, O. L., & Xie, X. Q. (2018). Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 4542-555. https://doi.org/10.1016/j.trci.2018.09.001
Hu, Ziheng, et al. "Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease." Alzheimer's & dementia (New York, N. Y.) vol. 4 (2018): 542-555. doi: https://doi.org/10.1016/j.trci.2018.09.001
Hu Z, Wang L, Ma S, Kirisci L, Feng Z, Xue Y, Klunk WE, Kamboh MI, Sweet RA, Becker J, Lv Q, Lopez OL, Xie XQ. Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimers Dement (N Y). 2018 Oct 14;4:542-555. doi: 10.1016/j.trci.2018.09.001. eCollection 2018. PMID: 30386819; PMCID: PMC6205113.
Copy Download .nbib Format: NLM
Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study.

Acta neuropathologica communications

Dugan AJ, Nelson PT, Katsumata Y, Shade LMP, Boehme KL, Teylan MA, Cykowski MD, Mukherjee S, Kauwe JSK, Hohman TJ, Schneider JA, Fardo DW.
PMID: 34526147
Acta Neuropathol Commun. 2021 Sep 15;9(1):152. doi: 10.1186/s40478-021-01250-2.

Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is the most prevalent subtype of TDP-43 proteinopathy, affecting up to 1/3rd of aged persons. LATE-NC often co-occurs with hippocampal sclerosis (HS) pathology. It is currently unknown why some individuals with LATE-NC...

Cite
Dugan AJ, Nelson PT, Katsumata Y, et al. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Commun. 2021;9(1):152doi: 10.1186/s40478-021-01250-2.
Dugan, A. J., Nelson, P. T., Katsumata, Y., Shade, L. M. P., Boehme, K. L., Teylan, M. A., Cykowski, M. D., Mukherjee, S., Kauwe, J. S. K., Hohman, T. J., Schneider, J. A., & Fardo, D. W. (2021). Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta neuropathologica communications, 9(1), 152. https://doi.org/10.1186/s40478-021-01250-2
Dugan, Adam J, et al. "Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study." Acta neuropathologica communications vol. 9,1 (2021): 152. doi: https://doi.org/10.1186/s40478-021-01250-2
Dugan AJ, Nelson PT, Katsumata Y, Shade LMP, Boehme KL, Teylan MA, Cykowski MD, Mukherjee S, Kauwe JSK, Hohman TJ, Schneider JA, Fardo DW. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Commun. 2021 Sep 15;9(1):152. doi: 10.1186/s40478-021-01250-2. PMID: 34526147; PMCID: PMC8442328.
Copy Download .nbib Format: NLM
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.

Molecular psychiatry

DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA.
PMID: 34112972
Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10.

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD, identifies a subgroup with poor outcomes, and is associated...

Cite
DeMichele-Sweet MAA, Klei L, Creese B, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021;26(10):5797-5811doi: 10.1038/s41380-021-01152-8.
DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Alarcón-Martín, E., Valero, S., Liu, Y., Hooli, B., Aarsland, D., Selbaek, G., Bergh, S., Rongve, A., Saltvedt, I., Skjellegrind, H. K., Engdahl, B., Stordal, E., Andreassen, O. A., Djurovic, S., Athanasiu, L., Seripa, D., Borroni, B., Albani, D., Forloni, G., Mecocci, P., Serretti, A., De Ronchi, D., Politis, A., Williams, J., Mayeux, R., Foroud, T., Ruiz, A., Ballard, C., Holmans, P., Lopez, O. L., Kamboh, M. I., Devlin, B., & Sweet, R. A. (2021). Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Molecular psychiatry, 26(10), 5797-5811. https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet, Mary Ann A, et al. "Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease." Molecular psychiatry vol. 26,10 (2021): 5797-5811. doi: https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10. PMID: 34112972; PMCID: PMC8660923.
Copy Download .nbib Format: NLM
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.

Molecular psychiatry

DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA.
PMID: 34112972
Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10.

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD, identifies a subgroup with poor outcomes, and is associated...

Cite
DeMichele-Sweet MAA, Klei L, Creese B, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021;26(10):5797-5811doi: 10.1038/s41380-021-01152-8.
DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Alarcón-Martín, E., Valero, S., Liu, Y., Hooli, B., Aarsland, D., Selbaek, G., Bergh, S., Rongve, A., Saltvedt, I., Skjellegrind, H. K., Engdahl, B., Stordal, E., Andreassen, O. A., Djurovic, S., Athanasiu, L., Seripa, D., Borroni, B., Albani, D., Forloni, G., Mecocci, P., Serretti, A., De Ronchi, D., Politis, A., Williams, J., Mayeux, R., Foroud, T., Ruiz, A., Ballard, C., Holmans, P., Lopez, O. L., Kamboh, M. I., Devlin, B., & Sweet, R. A. (2021). Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Molecular psychiatry, 26(10), 5797-5811. https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet, Mary Ann A, et al. "Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease." Molecular psychiatry vol. 26,10 (2021): 5797-5811. doi: https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021 Oct;26(10):5797-5811. doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10. PMID: 34112972; PMCID: PMC8660923.
Copy Download .nbib Format: NLM
Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease.

American journal of neurodegenerative disease

Rosenthal SL, Wang X, Demirci FY, Barmada MM, Ganguli M, Lopez OL, Kamboh MI.
PMID: 22984654
Am J Neurodegener Dis. 2012;1(2):191-8.

Late-onset Alzheimer's disease (LOAD) is a complex and multifactorial disease. So far ten loci have been identified for LOAD, including APOE, PICALM, CLU, BIN1, CD2AP, CR1, CD33, EPHA1, ABCA7, and MS4A4A/MS4A6E, but they explain about 50% of the genetic...

Cite
Rosenthal SL, Wang X, Demirci FY, et al. Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. Am J Neurodegener Dis. 2012;1(2):191-8
Rosenthal, S. L., Wang, X., Demirci, F. Y., Barmada, M. M., Ganguli, M., Lopez, O. L., & Kamboh, M. I. (2012). Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. American journal of neurodegenerative disease, 1(2), 191-8.
Rosenthal, Samantha L, et al. "Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease." American journal of neurodegenerative disease vol. 1,2 (2012): 191-8.
Rosenthal SL, Wang X, Demirci FY, Barmada MM, Ganguli M, Lopez OL, Kamboh MI. Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. Am J Neurodegener Dis. 2012;1(2):191-8. PMID: 22984654; PMCID: PMC3560458.
Copy Download .nbib Format: NLM
Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes.

Neurobiology of aging

Dugan AJ, Nelson PT, Katsumata Y, Shade LMP, Teylan MA, Boehme KL, Mukherjee S, Kauwe JSK, Hohman TJ, Schneider JA, Fardo DW.
PMID: 34852950
Neurobiol Aging. 2022 Mar;111:95-106. doi: 10.1016/j.neurobiolaging.2021.10.011. Epub 2021 Oct 29.

The genetic locus containing the WWOX and MAF genes was implicated as a clinical Alzheimer's disease (AD) risk locus in two recent large meta-analytic genome wide association studies (GWAS). In a prior GWAS, we identified a variant in WWOX...

Cite
Dugan AJ, Nelson PT, Katsumata Y, et al. Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes. Neurobiol Aging. 2021;111:95-106doi: 10.1016/j.neurobiolaging.2021.10.011.
Dugan, A. J., Nelson, P. T., Katsumata, Y., Shade, L. M. P., Teylan, M. A., Boehme, K. L., Mukherjee, S., Kauwe, J. S. K., Hohman, T. J., Schneider, J. A., Fardo, D. W. (2022). Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes. Neurobiology of aging, 11195-106. https://doi.org/10.1016/j.neurobiolaging.2021.10.011
Dugan, Adam J, et al. "Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes." Neurobiology of aging vol. 111 (2022): 95-106. doi: https://doi.org/10.1016/j.neurobiolaging.2021.10.011
Dugan AJ, Nelson PT, Katsumata Y, Shade LMP, Teylan MA, Boehme KL, Mukherjee S, Kauwe JSK, Hohman TJ, Schneider JA, Fardo DW. Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes. Neurobiol Aging. 2022 Mar;111:95-106. doi: 10.1016/j.neurobiolaging.2021.10.011. Epub 2021 Oct 29. PMID: 34852950; PMCID: PMC8761217.
Copy Download .nbib Format: NLM
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.

Molecular psychiatry

DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA.
PMID: 34112972
Mol Psychiatry. 2021 Jun 10; doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10.

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD, identifies a subgroup with poor outcomes, and is associated...

Cite
DeMichele-Sweet MAA, Klei L, Creese B, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021;doi: 10.1038/s41380-021-01152-8.
DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Alarcón-Martín, E., Valero, S., Liu, Y., Hooli, B., Aarsland, D., Selbaek, G., Bergh, S., Rongve, A., Saltvedt, I., Skjellegrind, H. K., Engdahl, B., Stordal, E., Andreassen, O. A., Djurovic, S., Athanasiu, L., Seripa, D., Borroni, B., Albani, D., Forloni, G., Mecocci, P., Serretti, A., De Ronchi, D., Politis, A., Williams, J., Mayeux, R., Foroud, T., Ruiz, A., Ballard, C., Holmans, P., Lopez, O. L., Kamboh, M. I., Devlin, B., & Sweet, R. A. (2021). Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Molecular psychiatry, . https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet, Mary Ann A, et al. "Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease." Molecular psychiatry vol. (2021). doi: https://doi.org/10.1038/s41380-021-01152-8
DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, Sims R, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Alarcón-Martín E, Valero S, Liu Y, Hooli B, Aarsland D, Selbaek G, Bergh S, Rongve A, Saltvedt I, Skjellegrind HK, Engdahl B, Stordal E, Andreassen OA, Djurovic S, Athanasiu L, Seripa D, Borroni B, Albani D, Forloni G, Mecocci P, Serretti A, De Ronchi D, Politis A, Williams J, Mayeux R, Foroud T, Ruiz A, Ballard C, Holmans P, Lopez OL, Kamboh MI, Devlin B, Sweet RA. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021 Jun 10; doi: 10.1038/s41380-021-01152-8. Epub 2021 Jun 10. PMID: 34112972; PMCID: PMC8660923.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries